Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study.

J Pharm Health Care Sci · 2024 · PMC11342735 · PMID 39180119

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Both normal SBP and high SBP groups showed an increasing trend for SBP and DBP from 1 month after the start of bevacizumab (+ 7.5 and + 11.7 mmHg, respectively), and a leveling off trend after 3 months (+ 11.6 and + 15.0 mmHg, respectively) (Fig. 1 b).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.